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Andrei E. Medvedev 1†
1Department of Immunology, UConn Health School of Medicine, Farmington, CT, United States, 2 Program in Innate
Immunity, Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical
School, Worcester, MA, United States
Long non-coding RNAs (lncRNAs) have emerged as key regulators of gene expression in
several biological systems. The long intergenic RNA-erythroid pro-survival (lincRNA-EPS)
has been shown to play a critical role in restraining inflammatory gene expression.
However, the function of lincRNA-EPS during bacterial infections remains unknown.
Here, we demonstrate that following infection with the intracellular bacterium Listeria
monocytogenes, both mouse macrophages and dendritic cells lacking lincRNA-EPS
exhibit an enhanced expression of proinflammatory cytokine genes, as well as an
increased expression of the inducible nitric oxide synthase (iNos) and nitric oxide (NO)
production. Importantly, we found that lincRNA-EPS−/− mice intraperitoneally infected
with L. monocytogenes exhibit lower bacterial burdens in spleen and liver and produce
more NO than control mice. Furthermore, lincRNA-EPS−/− mice are less susceptible to
a lethal dose of L. monocytogenes than wild type (WT) mice. Collectively these findings
show that lincRNA-EPS suppresses host protective NO expression and impairs the host
defense against L. monocytogenes infection.
Keywords: lncRNAs, infection, Listeria monocytogenes, innate immunity, lincRNA-EPS
INTRODUCTION
Long non-coding RNAs (lncRNAs) have recently emerged as key regulators of gene expression,
modulating a variety of transcriptional and translational events (Lee, 2012; Morris and Mattick,
2014). LncRNAs are arbitrarily defined as non-coding RNAs longer than 200 nucleotides, a feature
that distinguishes them from other non-coding transcripts, such as micro RNAs (miRNAs) and
small nucleolar RNAs (snoRNAs). Based on their genomic location lncRNAs are classified in
long intergenic non-coding RNAs (lincRNAs), bidirectional lncRNAs, intronic non-coding RNAs,
and natural antisense transcripts (NATs) (Murphy and Medvedev, 2016). The role of lncRNAs
in host defense is just emerging. LncRNA-ACOD1 was shown to facilitate viral infections by
directly binding and enhancing the catalytic activity of the metabolic enzyme glutamic-oxaloacetic
transaminase (GOT2) (Wang et al., 2017). During Salmonella enterica Typhimurium infection,
lncRNA NEAT1 was demonstrated promote the expression of immune related genes and blocking
Salmonella replication (Imamura et al., 2018).
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LincRNA-EPS was discovered in 2011 as a mammalian
lincRNA involved in erythroid differentiation (Hu et al., 2011).
Recently, lincRNA-EPS was shown to control nucleosome
positioning and the transcription of immune-related genes
(IRGs) (Atianand et al., 2016). LincRNA-EPS is abundantly
expressed and its expression is downregulated in response
to microbial ligands including lipopolysaccharide (LPS)
(Atianand et al., 2016). However, whether lincRNA-EPS
plays a role during bacterial infections is not known.
L. monocytogenes is a gram-positive, facultative intracellular
pathogen and is the causative agent of foodborne listeriosis. In
immunocompromised individuals L. monocytogenes can lead
to gastritis, septicemia and meningitis (Gellin and Broome,
1989; Mehmood et al., 2017); whereas, in pregnant women this
pathogen can cause infection to the fetus and septic abortion
(Pamer, 2004).
Here, we show the role of lincRNA-EPS in host defense
utilizing L. monocytogenes as amodel pathogen. L. monocytogenes
infection induces the downregulation of lincRNA-EPS expression
consistent with the previous report. Macrophages from
lincRNA-EPS−/− mice express significantly higher levels of
proinflammatory cytokines, such as TNF-α, IL-6, and CCL5
than control cells in response to L. monocytogenes infection.
Similarly, lncRNA-EPS−/− dendritic cells exhibited increased
TNF-α and IL-6 expression. Importantly, lincRNA-EPS−/−
mice controlled L. monocytogenes infection and survived
significantly better than wild type mice. Taken together,
these results demonstrate that during L. monocytogenes
infection, lincRNA-EPS suppresses bacterial clearance and host
defense responses.
MATERIALS AND METHODS
Mice and Primary Cells Isolation
C57BL/6J mice were from the Jackson Laboratory (BarHarbor,
ME). LincRNA-EPS−/−mice were provided by Dr. Katherine
Fitzgerald (University of Massachusetts Medical School,
Worcester, MA). Mice were housed in the University of
Connecticut Health Center animal facility, and 6–16 week-old
male and female mice were used. To generate bone marrow
derived macrophages (BMDMs), bone marrow cells from
femurs and tibias were differentiated for 7 days in DMEM
(Gibco, Dublin, Ireland), supplemented with 10% FBS (Atlanta
Biologicals, Flowery Branch, GA), 2mM L-glutamine, 100
U/ml penicillin, 100µg/ml streptomycin, and 15% L929
cell-conditioned, macrophage-colony-stimulating factor-
containing supernatant. Bone marrow derived dendritic cells
(BMDCs) were generated by differentiating bone marrow
cells in RPMI 1640 medium supplemented with 10% FBS,
100 U/ml penicillin, 100µg/ml streptomycin, 50µM 2-
mercaptoethanol, and recombinant GM-CSF (20 ng/ml)
for 10 days. All animal procedures and experiments were
approved by the Institutional Animal Care and Use Committee
(IACUC), the ethics committee responsible for reviewing the
use of animals in research and teaching at the University
of Connecticut.
Listeria monocytogenes Culture and
Infection
L. monocytogenes (10403S) was provided by Dr. Kamal Khanna
(New York University School of Medicine, New York, NY).
L. monocytogenes was cultured in brain heart infusion (BHI)
media containing 10µg/ml chloramphenicol. Bacteria were
grown to mid log phase and washed in PBS. For in vitro
experiments bacteria were added to cells cultured in antibiotic-
free medium at a multiplicity of infection (MOI) of 1 or
10 for 1.5 h. Cells were washed in PBS and incubated in
complete medium supplemented with 50µg/ml gentamycin for
the indicated time points. For in vivo experiments, mice were i.p.
administered L. monocytogenes 105 CFU. At the selected time
point, spleens, and livers were homogenized in PBS containing
protease and phosphatase inhibitors (Thermo Fisher Scientific,
Waltham, MA) for further analysis. For survival experiments
mice were i.p. administered L. monocytogenes 5 × 105 CFU and
observed for 10 days after infection.
Bacterial CFUs Count
BMDMs and BMDCs were grown overnight in 6-well plates
(2 × 106 cells/well) or in 24-well plates (0.4 × 106 cells/well),
infected for 1.5 h with L. monocytogenes (MOI of 1) in antibiotic
free medium, washed with PBS, incubated in completed medium
containing 50µg/ml gentamicin for the indicated times and
lysed in PBS containing 1% Triton X-100. Spleens and livers
from L. monocytogenes-infected mice were homogenized in PBS
containing protease and phosphatase inhibitors (ThermoFisher
Scientific). The number of CFUs per well or per gram of
organ homogenates was determined by plating 10-fold serial
dilutions of lysates on BHI agar plates containing 10µg/ml
chloramphenicol. Plates were incubated at 37◦C and CFUs were
counted after 18–24 h.
Extraction of RNA and Quantitative Real
Time PCR
Total RNAwas purified from cells and tissues using RNeasy RNA
extraction kit (Qiagen) as per the manufacturer’s instructions.
Genomic DNA was eliminated using on-column DNase I
digestion (Qiagen) and NanoDrop 2000 was used in order to
measure RNA quality. cDNA was prepared from equal amounts
of total RNA (50–1,000 ng), using iScript cDNA synthesis kit
(Bio-Rad). The following primers were used—Gapdh: 5′-GCT
GACCTGCTGGATTACATT-3′ (forward), 5′-GTTGAGAGA
TCATCTCCACCA-3′ (reverse); Tnfa: 5′-CCCAGGCAGTCA
GATCATCTTC-3′ (forward), 5′-GCTTGAGGGTTTGCTACA
ACATG-3′ (reverse); iNos: 5′-CGCCTTCAACACCAAGGT
TG-3′ (forward), 5′TGGGGACAGTCTCCATTCCCA-3′; Il6: 5′-
TCAGGAAATTTGCCTATTGAAAATTT-3′ (forward), 5′-GCT
TTGTCTTTCTTGTTATCTTTTAAGTTGT-3′ (reverse); Ccl5:
5′-GAGTGACAAACACGACTGCAAGAT-3′ (forward), 5′-CT
GCTTTGCCTACCTCTCCC T-3′ (reverse); Kc: 5′-CCATGG
CTGGGATTCACC-3′ (forward), 5′GACCATTCTTGAGTGTG
GCTATGAC-3′ (reverse); 16S V6: 5′-TCGATGCAACGCGAA
GAA-3′-(forward), 5′-ACATTTCACAACACGAGCTGACGA-
3′ (reverse). Gene expression levels were normalized to Gapdh as
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housekeeping gene. Relative mRNA expressions were calculated
according to the 2−11t calculation method. Specificity of PCR
amplifications was assessed by melting curve analysis.
Cytokine Secretion and NO Release
Supernatants from cell cultures and tissue homogenates were
cleared by centrifugation (2,000 g, 10min), and cytokine levels
were determined by ELISA using commercial kits: Ccl5/Rantes
(R&D Systems), Cxcl1/KC (R&D Systems), IL-6 (BioLegend,
San Diego, CA), TNF-α (BioLegend, San Diego, CA), IL-1β
(BioLegend, San Diego, CA). Nitrite (NO2−) concentrations in
the supernatants and organ homogenates were examined by the
Griess method. In brief, 1% sulfanilamide in 2.5% phosphoric
acid-0.1% n-1-napthylethylenediamide dichlorique was added to
50 µl of samples and after 20min of incubation absorbance
was read at 540 nm. NO2− was quantified using sodium nitrite
(NaNO2) as a standard.
Western Blot Analysis
BMDMs were infected with L. monocytogenes as described
above and lysed in lysis buffer (50mM Tris–HCl, pH 7.4,
150mM NaCl, 1% Triton X-100, 1mM EDTA, 5mM NaF,
2mM sodium orthovanadate, 1mMPMSF, 1X complete protease
inhibitors). The whole cell lysates were mixed with Laemmli
buffer (50mm Tris–Cl, pH 6.8, 10% glycerol, 2% SDS, 0.1%
bromophenol blue, 5% 2-mercaptoethanol), boiled for 5min,
separated on 4–20% polyacrylamide gels (BioRad), transferred
to nitrocellulose membranes (Bio-Rad), blocked, and probed
with the following primary antibodies: monoclonal Ab to
iNOS (clone D6B6S, Cell Signaling) and polyclonal Ab to
β-actin (Sigma). Membranes were developed using an ECL
plus chemiluminescence kit (Thermo Fisher Scientific) and
protein quantification on the Western blots was performed using
GeneTools software (Syngene).
Statistics
The statistical significance was determined with unpaired,
two-tailed Student’s t-test and the survival data were analyzed
using Log-rank (Mantel-Cox) test. p ≤ 0.05 was considered
statistically significant. Data were processed by the GraphPad
Prism 8.0 software package (Graph Pad Software, San
Diego, CA) and expressed as mean ± SEM of at least two
independent experiments.
RESULTS
LincRNA-EPS Restrains
L. monocytogenes-Induced Immune Gene
Expression in Mouse Macrophages
A pervious study showed that the expression of lincRNA-EPS is
downregulated in WT BMDMs infected with L. monocytogenes
(Atianand et al., 2016). Furthermore, lincRNA-EPS is a negative
regulator of inflammatory response in mouse macrophages
exposed to LPS (Atianand et al., 2016). As infection by
L. monocytogenes is initially controlled by macrophages (Wing
and Remington, 1977), we wondered whether lincRNA-EPS
might play a role in macrophages during this bacterial infection.
For this purpose, BMDMs isolated from WT and lincRNA-
EPS−/− mice were infected with L. monocytogenes and we
measured the expression of proinflammatory cytokines and
chemokines at both mRNA and protein levels. We found that
L. monocytogenes-induced expression of Il6, Tnfa, Il1b and
Ccl5 was significantly upregulated in lincRNA-EPS−/− BMDMs
compared to control cells (Figure 1A); whereas no difference was
observed in KC expression. These results were further confirmed
at the protein level (Figure 1B). Taken together these data
indicate that lincRNA-EPS acts as restrainer of L. monocytogenes-
induced immune genes expression in mouse macrophages.
LincRNA-EPS Controls
L. monocytogenes-Induced Immune Gene
Expression in Mouse Dendritic Cells
Next, we hypothesized that following L. monocytogenes infection
lincRNA-EPS might have a role in innate immune cell types
other than macrophages. Dendritic cells are innate immune
cells well known to be involved in L. monocytogenes infection
(Serbina et al., 2003; Tam and Wick, 2004). As observed in
macrophages, DCs also downregulate lincRNA-EPS expression
following L. monocytogenes infection (Figure 2A). We further
measured the levels of immune related cytokines and chemokines
produced by WT and lincRNA-EPS−/− BMDCs. We found
that compared to WT cells, IL-6, and TNF-α were significantly
up regulated in lincRNA-EPS−/− BMDCs at both mRNA
(Figure 2B) and protein levels (Figure 2C); on the contrary,
the expression of IL-1β, CCL5, and KC was not altered in
lincRNA-EPS−/− cells. Collectively, these results demonstrate
that lincRNA-EPS expression is negatively regulated in response
to L. monocytogenes infection in mouse dendritic cells and
lincRNA-EPS downregulation leads to the upregulation of
proinflammatory cytokines, such as IL-6 and TNF-α.
LincRNA-EPS Promotes L. monocytogenes
Replication in vitro and in vivo
Next, we examined whether the L. monocytogenes-induced
lincRNA-EPS downregulation might affect the intracellular
bacterial replication in mouse macrophages and dendritic cells.
Infection of WT and lincRNA-EPS−/− BMDMs or BMDCs with
L. monocytogenes resulted in a comparable number of bacterial
colony forming units (CFUs) immediately after infection
[between 1 and 3 h post infection (hpi)] (Figures 3A,B).
However, compared with WT cells, significantly lower CFUs
were recovered from lincRNA-EPS−/− BMDMs and BMDCs
at 18 hpi with L. monocytogenes (Figures 3A,B). Furthermore,
the bacterial 16S ribosomal mRNA measured at 6 hpi by qPCR
was significantly lower in lincRNA-EPS−/− BMDMs compared
to WT cells (Figure 3A). LincRNA-EPS was shown to restrain
inflammation in mice exposed to LPS, with a significantly higher
mortality rate in lincRNA-EPS−/− mice (Atianand et al., 2016).
However, the role of lincRNA-EPS during bacterial infection
in vivo remains unknown. We noticed that lincRNA-EPS
expression is significantly downregulated in the spleen following
L. monocytogenes infection (Supplementary Figure 1A).
Furthermore, after L. monocytogenes infection of WT and
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FIGURE 1 | LincRNA-EPS restrains L. monocytogenes-induced immune gene expression in BMDMs. (A) mRNA levels of cytokine and chemokine genes in WT and
lincRNA-EPS−/− BMDMs after 3 h of L. monocytogenes infection (MOI of 1). (B) Protein levels of cytokines and chemokine in WT and lincRNA-EPS−/− BMDMs after
6 h of L. monocytogenes infection (MOI of 1). An unpaired, two-tailed Student’s t-test was performed to determine statistical significance. Data are shown as mean ±
SEM of at least two independent experiments. ***p = 0.0006; **p = 0.001; *1p = 0.03; *2p = 0.02; *3p = 0.05; *4p = 0.03; *5p = 0.02; *6p = 0.02; ns, not significant.
lincRNA-EPS−/− mice, we monitored bacterial clearance
and cytokine responses. As shown in Figure 4A, significantly
lower CFUs were detected at 48 hpi in the spleen and liver of
L. monocytogenes-infected lincRNA-EPS−/− mice compared
to WT mice, suggesting that lincRNA-EPS enhances bacterial
replication in vivo. However, none of the analyzed cytokines
showed altered expression in the infected lincRNA-EPS−/− mice
compared to WT (Supplementary Figures 1B,C). Furthermore,
we infected WT and lincRNA-EPS−/− mice with a lethal dose
of L. monocytogenes and we monitored them for weight loss
and survival. Strikingly, lincRNA-EPS−/− mice lost significantly
less body weight than WT mice (Figure 4B) and consistent
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FIGURE 2 | LincRNA-EPS restrains L. monocytogenes-induced immune gene expression in BMDCs. (A) LincRNA-EPS mRNA level in WT BMDCs after 6 h of
L. monocytogenes infection (MOI of 1). (B) mRNA levels of cytokine and chemokine genes in WT and lincRNA-EPS−/− BMDCs after 6 h of L. monocytogenes
infection (MOI of 1). (C) Protein levels of cytokines and chemokines in WT and lincRNA-EPS−/− BMDCs after 6 h of Listeria infection (MOI of 1). Unpaired, two-tailed
Student’s t-test was performed to determine statistical significance. Data are shown as mean ± SEM of at least two independent experiments. **p = 0.009; *1p =
0.05; *2p = 0.01; *3p = 0.03; *4p = 0.02; ns, not significant.
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FIGURE 3 | LincRNA-EPS promotes L. monocytogenes replication in vitro. (A) CFU counts in WT and lincRNA-EPS−/− BMDMs after 18 h of Listeria infection (MOI of
1) (left) and mRNA levels of bacterial 16S in WT and lincRNA-EPS−/− BMDMs after 6 h of L. monocytogenes infection (MOI of 1) (right). (B) CFU counts in WT and
lincRNA-EPS−/− BMDCs after 18 h of L. monocytogenes infection (MOI of 1). Unpaired, two-tailed Student’s t-test was performed to determine statistical significance.
Data are shown as mean ± SEM of at least two independent experiments. *1p = 0.01; *2p = 0.04; *3p = 0.04; ns, not significant.
FIGURE 4 | LincRNA-EPS promotes L. monocytogenes replication in vivo. (A) CFU count in 1 g of spleen (left) and liver (right) of WT and lincRNA-EPS−/− mice after
72 h of L. monocytogenes infection (105 CFUs/mouse). (B) Weight loss in WT and lincRNA-EPS mice monitored for 10 days after i.p. Listeria monocytogenes infection
(5 × 105 CFUs/mouse). (C) Survival rate in WT and lincRNA-EPS−/− mice monitored for 10 days after i.p. L. monocytogenes infection (5 × 105 CFUs/mouse). In (A)
unpaired, two-tailed Student’s t-test was performed to determine statistical significance. In (B) two-way ANOVA with the Bonferroni post-hoc test was performed to
determine statistical significance. In (C) a Log-rank (Mantel-Cox) test was performed to determine statistical significance. Data are shown as mean ± SEM of at least
two independent experiments. **p = 0.003; *1p = 0.03; *2p = 0.05; *3p = 0.03; *4p = 0.01; *5p = 0.02; *6p = 0.04.
with this result, lincRNA-EPS−/− mice were significantly less
susceptible to L. monocytogenes infection. In fact, 70% of WT
mice succumbed to death, whereas only 25% of the lincRNA-
EPS−/− mice died (Figure 4C). Collectively, these results
indicate that during L. monocytogenes infection, lincRNA-EPS
promotes bacterial survival in both mouse macrophages and
dendritic cells and has also a crucial role in bacterial clearance
and host survival in vivo.
LincRNA-EPS Inhibits iNos Expression and
NO Production
Enhanced bacterial clearance in vitro and in vivo in the absence of
lincRNA-EPS suggested that lincRNA-EPS might be suppressing
cellular antimicrobial mechanisms. Several studies showed that
induced iNOS and nitric oxide (NO) are critical antimicrobic
mediator in host defense against L. monocytogenes (Boockvar
et al., 1994; Macmicking et al., 1995; Serbina et al., 2003).
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 6 January 2020 | Volume 9 | Article 481
Agliano et al. LincRNA-EPS Inhibits Innate Immune Responses
FIGURE 5 | LincRNA-EPS restrains L. monocytogenes-induced iNos expression and NO production. (A) mRNA levels of iNos in WT and lincRNA-EPS−/− BMDMs
(left) and BMDCs (right) after L. monocytogenes infection (MOI of 1). (B) Immunoblots of iNOS and β-actin in lysates of BMDMs untreated or stimulated with
L. monocytogenes (MOI of 10) for 6 h. (C) NO production in WT and lincRNA-EPS−/− BMDMs (left) and BMDCs (right) after 48 h of L. monocytogenes infection (MOI
of 1). (D) NO production in spleen (left) and liver (right) of WT and lincRNA-EPS−/− mice after 48 h of L. monocytogenes infection (105 CFUs/mouse). Unpaired,
two-tailed Student’s t-test was performed to determine statistical significance. Data are shown as mean ± SEM of at least two independent experiments. *1p = 0.03;
*2p = 0.03; *3p = 0.01; *4p = 0.01; *5p = 0.01.
Thus, we hypothesized that during L. monocytogenes infection,
lincRNA-EPS might be crucial in controlling iNOS expression
and the consequent NO production. Toward this end, we exposed
BMDMs and BMDCs to L. monocytogenes and analyzed iNos
expression by qPCR at 3 and 6 hpi, respectively. We found
that BMDMs and BMDCs from lincRNA-EPS−/− mice express
significantly higher levels of iNOS than WT at both mRNA and
protein levels (Figures 5A,B). Consistently, lincRNA-EPS−/−
macrophages and dendritic cells produce significantly higher
amounts of NO compared to control cells (Figure 5C). We
further tested the effect of lincRNA-EPS on NO production in
vivo. As shown in Figure 5D, NO production measured in liver
of lincRNA-EPS−/− mice at 48 hpi was significantly higher than
WT mice, and a similar trend, albeit of lower magnitude, was
observed in the spleen. Taken together these results demonstrate
that lincRNA-EPS controls iNos expression and the production
of NO during L. monocytogenes infection, which could impair
bacterial clearance.
DISCUSSION
LncRNAs are emerging as regulators of inflammatory responses
of immune cells and host-pathogen interactions. LincRNA-EPS
is a nuclear intergenic long non-coding RNA showed to act as a
transcriptional brake to restrain inflammation (Atianand et al.,
2016). Furthermore, lincRNA-EPS is downregulated in mouse
macrophages after infection with the gram-positive bacterium
Listeria monocytogenes (Atianand et al., 2016). However, the
role of lincRNA-EPS in host responses to bacterial infections
remained unknown.
In this paper we showed that macrophages lacking lincRNA-
EPS exhibit increased expression of inflammatory cytokines
such as TNF-α, IL-6, IL1-β, and CCL5 upon infection with
L. monocytogenes. Consistently, compared to WT cells, lincRNA-
EPS-deficient dendritic cells infected with L. monocytogenes
showed upregulated expression of TNF-α and IL-6; whereas IL1-
β and CCL5 were not differentially expressed. Thus, lincRNA-
EPS seems to exert a stronger effect in BMDMs, which are
likely to be more sensitive to lincRNA-EPS-dependent molecular
events than are BMDCs. Another possibility might be that the
constitutive expression of lincRNA-EPS is higher in BMDMs,
where it exerts a more robust transcriptional control.
Furthermore, we showed that the expression of lincRNA-EPS
is strongly downregulated in BMDCs during L. monocytogenes
infection, as it was shown in BMDMs (Atianand et al., 2016).
Although it is still not known what drives lincRNA-EPS
downregulation in response to L. monocytogenes infection, it
is likely that the host responds to L. monocytogenes inducing
the expression of one or more molecules that might be able to
promote the downregulation of lincRNA-EPS, which would be a
result of the host molecular mechanism of defense. Alternatively,
a Listeria-derived molecule might directly or indirectly induce
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 7 January 2020 | Volume 9 | Article 481
Agliano et al. LincRNA-EPS Inhibits Innate Immune Responses
the downregulation of lincRNA-EPS. Furthermore, Atianand and
al. showed that the TLR-dependent suppression of lincRNA-EPS
was dependent on MyD88 and TRIF (Atianand et al., 2016), thus
these two molecules might be also critical in modulating the
expression of lincRNA-EPS during L. monocytogenes infection.
Compared with WT cells, lincRNA-EPS-deficient BMDMs
and BMDCs showed equal infectivity at the start of infection,
indicating that the increased cytokine responses cannot be
explained by higher microbial burdens. Of note, at late time
points post-infection, both BMDMs and BMDCs lacking
lincRNA-EPS harbored lower bacterial loads, suggesting
enhanced bacterial clearance. These findings were supported by
a higher production of iNOS and nitrates in lincRNA-EPS−/−
cells compared to controls. To uncover the role of lincRNA-
EPS in eliciting immune responses during infections with
intracellular bacteria in vivo, we analyzed cytokine expression
in WT and lincRNA-EPS−/− mice after systemic infection with
L. monocytogenes. Although the loss of lincRNA-EPS did not
alter the cytokine production in spleen and liver of mice infected
with L. monocytogenes, NO production is higher in lincRNA-
EPS-deficient mice compared to WT. The lack of differences
in cytokine levels in vivo between WT and lincRNA-EPS−/−
mice might be explained by the fact that lincRNA-EPS may be
mainly expressed and has a prominent effect in splenic and liver
macrophages and dendritic cells; thus, any possible differences
in these two populations would be masked by other cells
types, where lincRNA-EPS might not play a role. An alternate
possibility is that unlike its important role in iNOS expression
and bacterial clearance, lincRNA-EPS’s role in cytokine responses
might be redundant in vivo. Consistent with the higher NO
production, bacterial CFUs in spleen and liver following i.p.
infection with L. monocytogenes were significantly reduced in
lincRNA-EPS−/− mice compared to WT. Published studies
provide strong evidence that inhibition of iNOS expression
results in increased susceptibility to listeriosis (Macmicking
et al., 1995; Serbina et al., 2003); furthermore, NO is one of the
major bactericidal mediators involved in host defense against
L. monocytogenes (Boockvar et al., 1994). Therefore, it is possible
that the enhanced bacterial clearance and host survival observed
in lincRNA-EPS−/− mice could be mediated by the elevated
NO production.
At a steady state, lincRNA-EPS has been shown to maintain
a repressed chromatin state at immune related genes, inhibiting
their expression (Atianand et al., 2016). Furthermore, lincRNA-
EPS interacts with the ribonucleoprotein hnRNPL (Atianand
et al., 2016), known to control transcriptional regulation of
gene expression (Huang et al., 2012; Giraud et al., 2014; Li
et al., 2014). Thus, it is likely that during L. monocytogenes
infection, downregulation of lincRNA-EPS leads to an increased
production of proinflammatory cytokines and iNOS in splenic
and liver macrophages and dendritic cells, followed by a general
enhancement of NO production in vivo. This results in a
more efficient immune response and bacterial clearance when
lincRNA-EPS is completely absent. However, further studies are
necessary in order to better elucidate the molecular mechanism
by which lincRNA-EPS restrains iNOS during L. monocytogenes
infection. In summary, our study reveals a critical role for
lincRNA-EPS in anti-bacterial host defense. These findings
further improve our understanding of the role of lncRNAs in
host-pathogen interactions and in the regulation of immune
responses during infection.
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